Conestoga Capital Advisors released its third-quarter 2025 investor letter, reporting that the Conestoga Micro-Cap Composite returned 11.7% net-of-fees, compared to the Russell Microcap Growth Index’s return of 19.9%. Alpha Teknova, Inc. (NASDAQ:TKNO) is a leading provider of critical reagents for the life science market, with a one-month return of 1.13% and a market capitalization of $274.533 million.

In its investor letter, Conestoga Capital Advisors highlighted the demand for life science reagents and critical raw materials, particularly in biopharma and advanced therapies. Alpha Teknova, Inc. (NASDAQ:TKNO) has seen a rally in shares due to progress toward profitability and positive exposure to cell and gene therapy development.

Alpha Teknova, Inc. (NASDAQ:TKNO) is not among the 30 Most Popular Stocks Among Hedge Funds. The company reported a total revenue of $10.3 million in Q2 2025, up 7% from the previous year. While Alpha Teknova, Inc. (NASDAQ:TKNO) shows potential as an investment, certain AI stocks offer greater upside potential with less downside risk.

Read more at Yahoo Finance: Alpha Teknova (TKNO) Surged Following Accelerated Demand